JPY 227.0
(-0.44%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 289.67 Million JPY | -88.52% |
2022 | 2.52 Billion JPY | -5.6% |
2021 | 2.67 Billion JPY | 108.02% |
2020 | 1.28 Billion JPY | 293.64% |
2019 | 326.32 Million JPY | 40.03% |
2018 | 233.03 Million JPY | -39.55% |
2017 | 385.51 Million JPY | -38.61% |
2016 | 628.01 Million JPY | 1.58% |
2015 | 618.27 Million JPY | -15.98% |
2014 | 735.87 Million JPY | 9.57% |
2013 | 671.58 Million JPY | -16.96% |
2012 | 808.74 Million JPY | -26.02% |
2011 | 1.09 Billion JPY | 33.18% |
2010 | 820.83 Million JPY | 27.68% |
2009 | 642.86 Million JPY | -14.45% |
2008 | 751.48 Million JPY | -19.51% |
2007 | 933.58 Million JPY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 FY | 289.67 Million JPY | -88.52% |
2023 Q4 | 289.67 Million JPY | -17.93% |
2023 Q3 | 352.96 Million JPY | -84.34% |
2023 Q2 | 2.25 Billion JPY | -5.02% |
2023 Q1 | 2.37 Billion JPY | -5.89% |
2022 Q1 | 2.94 Billion JPY | 10.28% |
2022 FY | 2.52 Billion JPY | -5.6% |
2022 Q4 | 2.52 Billion JPY | -11.67% |
2022 Q3 | 2.85 Billion JPY | 0.53% |
2022 Q2 | 2.84 Billion JPY | -3.6% |
2021 FY | 2.67 Billion JPY | 108.02% |
2021 Q1 | 1.42 Billion JPY | 10.64% |
2021 Q4 | 2.67 Billion JPY | 40.04% |
2021 Q3 | 1.9 Billion JPY | -4.55% |
2021 Q2 | 1.99 Billion JPY | 40.65% |
2020 Q1 | 366.06 Million JPY | 12.18% |
2020 Q2 | 320.89 Million JPY | -12.34% |
2020 Q4 | 1.28 Billion JPY | 361.18% |
2020 FY | 1.28 Billion JPY | 293.64% |
2020 Q3 | 278.52 Million JPY | -13.2% |
2019 FY | 326.32 Million JPY | 40.03% |
2019 Q1 | 195.31 Million JPY | -16.19% |
2019 Q2 | 353.5 Million JPY | 80.99% |
2019 Q3 | 284.87 Million JPY | -19.41% |
2019 Q4 | 326.32 Million JPY | 14.55% |
2018 Q2 | 251.87 Million JPY | -14.71% |
2018 Q4 | 233.03 Million JPY | -13.93% |
2018 FY | 233.03 Million JPY | -39.55% |
2018 Q1 | 295.31 Million JPY | -23.4% |
2018 Q3 | 270.75 Million JPY | 7.49% |
2017 Q4 | 385.51 Million JPY | -15.55% |
2017 FY | 385.51 Million JPY | -38.61% |
2017 Q3 | 456.51 Million JPY | -14.54% |
2017 Q2 | 534.16 Million JPY | -13.86% |
2017 Q1 | 620.12 Million JPY | -1.26% |
2016 Q4 | 628.01 Million JPY | -12.24% |
2016 Q3 | 715.58 Million JPY | -0.82% |
2016 Q1 | 567.21 Million JPY | -8.26% |
2016 Q2 | 721.47 Million JPY | 27.2% |
2016 FY | 628.01 Million JPY | 1.58% |
2015 Q2 | 711.36 Million JPY | 10.15% |
2015 Q1 | 645.82 Million JPY | -12.24% |
2015 Q4 | 618.27 Million JPY | 1.23% |
2015 Q3 | 610.75 Million JPY | -14.14% |
2015 FY | 618.27 Million JPY | -15.98% |
2014 Q2 | 553.63 Million JPY | 1.22% |
2014 FY | 735.87 Million JPY | 9.57% |
2014 Q4 | 735.87 Million JPY | -16.02% |
2014 Q3 | 876.22 Million JPY | 58.27% |
2014 Q1 | 546.94 Million JPY | -18.56% |
2013 Q2 | 815.52 Million JPY | 21.5% |
2013 Q3 | 805.75 Million JPY | -1.2% |
2013 Q4 | 671.58 Million JPY | -16.65% |
2013 Q1 | 671.24 Million JPY | -17.0% |
2013 FY | 671.58 Million JPY | -16.96% |
2012 Q1 | 956.29 Million JPY | -12.52% |
2012 Q3 | 879.58 Million JPY | -10.05% |
2012 Q4 | 808.74 Million JPY | -8.05% |
2012 FY | 808.74 Million JPY | -26.02% |
2012 Q2 | 977.9 Million JPY | 2.26% |
2011 Q4 | 1.09 Billion JPY | 5.0% |
2011 FY | 1.09 Billion JPY | 33.18% |
2011 Q3 | 1.04 Billion JPY | -1.29% |
2011 Q2 | 1.05 Billion JPY | -8.17% |
2011 Q1 | 1.14 Billion JPY | 39.93% |
2010 Q1 | 719.22 Million JPY | 11.88% |
2010 FY | 820.83 Million JPY | 27.68% |
2010 Q3 | 933.19 Million JPY | 23.62% |
2010 Q4 | 820.83 Million JPY | -12.04% |
2010 Q2 | 754.9 Million JPY | 4.96% |
2009 Q4 | 642.86 Million JPY | -3.56% |
2009 Q3 | 666.58 Million JPY | 22.12% |
2009 Q2 | 545.85 Million JPY | 3.78% |
2009 Q1 | 525.96 Million JPY | -30.01% |
2009 FY | 642.86 Million JPY | -14.45% |
2008 Q4 | 751.48 Million JPY | -9.04% |
2008 Q3 | 826.19 Million JPY | 2.12% |
2008 Q2 | 809.07 Million JPY | 0.0% |
2008 FY | 751.48 Million JPY | -19.51% |
2007 FY | 933.58 Million JPY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 18.14 Billion JPY | 98.404% |
DNA Chip Research Inc. | - JPY | -Infinity% |
Cosmo Bio Company,Limited | - JPY | -Infinity% |
H.U. Group Holdings, Inc. | 60.1 Billion JPY | 99.518% |
FALCO HOLDINGS Co., Ltd. | 148 Million JPY | -95.725% |
BML, Inc. | 3.73 Billion JPY | 92.238% |
Human Metabolome Technologies, Inc. | 11.34 Million JPY | -2453.535% |